Literature DB >> 6711540

Urinary tract infection and risk of bladder cancer.

A F Kantor, P Hartge, R N Hoover, A S Narayana, J W Sullivan, J F Fraumeni.   

Abstract

In an epidemiologic study of 2982 bladder carcinoma patients and 5782 population controls from 10 geographic areas of the United States, the role of urinary tract infection and inflammation in the etiology of this neoplasm was evaluated. A history of urinary tract infection significantly elevated the risk of bladder cancer, particularly in individuals who reported three or more infections (relative risk (RR) = 2.0). Significantly increased bladder cancer risk was also found for bladder stones (RR = 1.8), while kidney stones showed no relation. A history of three or more urinary tract infections was strongly related to squamous cell carcinoma in particular (RR = 4.8).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6711540     DOI: 10.1093/oxfordjournals.aje.a113768

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  57 in total

Review 1.  BCG response prediction with cytokine gene variants and bladder cancer: where we are?

Authors:  Dinesh Kumar Ahirwar; Parmeet Kaur Manchanda; Rama Devi Mittal; Hemant K Bid
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-20       Impact factor: 4.553

2.  Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy.

Authors:  Wassim Kassouf; Ashish M Kamat; Alexander Zlotta; Bernard H Bochner; Ronald Moore; Alan So; Jonathan Izawa; Ricardo A Rendon; Louis Lacombe; Armen G Aprikian
Journal:  Can Urol Assoc J       Date:  2010-06       Impact factor: 1.862

3.  CUA guidelines on the management of non-muscle invasive bladder cancer.

Authors:  Wassim Kassouf; Samer L Traboulsi; Girish S Kulkarni; Rodney H Breau; Alexandre Zlotta; Andrew Fairey; Alan So; Louis Lacombe; Ricardo Rendon; Armen G Aprikian; D Robert Siemens; Jonathan I Izawa; Peter Black
Journal:  Can Urol Assoc J       Date:  2015-10-13       Impact factor: 1.862

4.  Diabetes and risk of bladder cancer: evidence from a case-control study in New England.

Authors:  Todd MacKenzie; Michael S Zens; Assiamira Ferrara; Alan Schned; Margaret R Karagas
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

Review 5.  Covert operations of uropathogenic Escherichia coli within the urinary tract.

Authors:  Jean M Bower; Danelle S Eto; Matthew A Mulvey
Journal:  Traffic       Date:  2005-01       Impact factor: 6.215

Review 6.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

7.  Macrophage migration inhibitory factor gene -173G>C polymorphism and risk of bladder cancer in southeast China: a case-control analysis.

Authors:  Qinbo Yuan; Meilin Wang; Miaomiao Wang; Zhengdong Zhang; Wei Zhang
Journal:  Mol Biol Rep       Date:  2011-07-13       Impact factor: 2.316

8.  Comparison of the descriptive epidemiology of urinary tract cancers.

Authors:  S S Devesa; D T Silverman; J K McLaughlin; C C Brown; R R Connelly; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1990-09       Impact factor: 2.506

Review 9.  Epigenetic modifications of the immune system in health and disease.

Authors:  Yuuki Obata; Yukihiro Furusawa; Koji Hase
Journal:  Immunol Cell Biol       Date:  2015-02-10       Impact factor: 5.126

Review 10.  Role of oestrogen receptors in bladder cancer development.

Authors:  Iawen Hsu; Spencer Vitkus; Jun Da; Shuyuan Yeh
Journal:  Nat Rev Urol       Date:  2013-04-16       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.